Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients

被引:41
作者
Abdollahzadeh, Rasoul [1 ]
Shushizadeh, Mohammad Hossein [2 ]
Barazandehrokh, Mina [3 ]
Choopani, Sepideh [4 ]
Azarnezhad, Asaad [5 ]
Paknahad, Sahereh [1 ]
Pirhoushiaran, Maryam [1 ]
Makani, S. Zahra [6 ]
Yeganeh, Razieh Zarifian [1 ]
Al-Kateb, Ahmed [7 ]
Heidarzadehpilehrood, Roozbeh [8 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Dept Med Genet, Tehran, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Pasteur Med Lab, Ahvaz, Iran
[3] Islamic Azad Univ IAUPS, Fac Adv Sci & Technol, Pharmaceut Sci Branch, Tehran, Iran
[4] Islamic Azad Univ, Tehran Med Sci, Tehran, Iran
[5] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Liver & Digest Res Ctr, Sanandaj, Iran
[6] Babol Razi Pathol & Genet Lab, Babol, Iran
[7] Univ Tehran Med Sci, Dept Med Genet, Fac Med, Tehran, Iran
[8] Univ Putra Malaysia, Dept Obstet Gynaecol, Fac Med & Hlth Sci, Seri Kembangan, Malaysia
关键词
COVID-19; Vitamin D receptor; Single nucleotide polymorphisms (SNPs); Genetic predisposition; Clinical outcomes; ACUTE LUNG INJURY; D DEFICIENCY; MULTIPLE-SCLEROSIS; VDR POLYMORPHISMS; D METABOLITES; RISK; CONSEQUENCES; CORONAVIRUS; POPULATION; PREVALENCE;
D O I
10.1016/j.meegid.2021.105098
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Growing evidence documented the critical impacts of vitamin D (VD) in the prognosis of COVID-19 patients. The functions of VD are dependent on the vitamin D receptor (VDR) in the VD/VDR signaling pathway. Therefore, we aimed to assess the association of VDR gene polymorphisms with COVID-19 outcomes. Methods: In the present study, eight VDR single nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 500 COVID-19 patients in Iran, including 160 asymptomatic, 250 mild/moderate, and 90 severe/critical cases. The association of these polymorphisms with severity, clinical outcomes, and comorbidities were evaluated through the calculation of the Odds ratio (OR). Results: Interestingly, significant associations were disclosed for some of the SNP-related alleles and/or genotypes in one or more genetic models with different clinical data in COVID-19 patients. Significant association of VDRSNPs with signs, symptoms, and comorbidities was as follows: ApaI with shortness of breath (P < 0.001) and asthma (P = 0.034) in severe/critical patients (group III); BsmI with chronic renal disease (P = 0.010) in mild/ moderate patients (group II); Tru9I with vomiting (P = 0.031), shortness of breath (P = 0.04), and hypertension (P = 0.030); FokI with fever and hypertension (P = 0.027) in severe/critical patients (group III); CDX2 with shortness of breath (P = 0.022), hypertension (P = 0.036), and diabetes (P = 0.042) in severe/critical patients (group III); EcoRV with diabetes (P < 0.001 and P = 0.045 in mild/moderate patients (group II) and severe/ critical patients (group III), respectively). However, the association of VDR TaqI and BglI polymorphisms with clinical symptoms and comorbidities in COVID-19 patients was not significant. Conclusion: VDR gene polymorphisms might play critical roles in the vulnerability to infection and severity of COVID-19, probably by altering the risk of comorbidities. However, these results require further validation in larger studies with different ethnicities and geographical regions.
引用
收藏
页数:24
相关论文
共 93 条
[1]   Association of VDR gene polymorphisms with risk of relapsing-remitting multiple sclerosis in an Iranian Kurdish population [J].
Abdollahzadeh, Rasoul ;
Pordanjani, Parisa Moradi ;
Rahmani, Farideh ;
Mashayekhi, Fatemeh ;
Azarnezhad, Asaad ;
Mansoori, Yaser .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2018, 128 (06) :505-511
[2]   Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study [J].
Abdollahzadeh, Rasoul ;
Fard, Mahsa Sobhani ;
Rahmani, Farideh ;
Moloudi, Kaveh ;
Kalani, Behrooz Sadeghi ;
Azarnezhad, Asaad .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 367 :148-151
[3]   COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence [J].
Adir, Yochai ;
Humbert, Marc ;
Saliba, Walid .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (02) :361-+
[4]   Role of vitamin D in preventing of COVID-19 infection, progression and severity [J].
Ali, Nurshad .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (10) :1373-1380
[5]   Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation [J].
Alzaman, Naweed S. ;
Dawson-Hughes, Bess ;
Nelson, Jason ;
D'Alessio, David ;
Pittas, Anastassios G. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2016, 104 (01) :205-214
[6]   Vitamin D deficiency 2.0: an update on the current status worldwide [J].
Amrein, Karin ;
Scherkl, Mario ;
Hoffmann, Magdalena ;
Neuwersch-Sommeregger, Stefan ;
Koestenberger, Markus ;
Berisha, Adelina Tmava ;
Martucci, Gennaro ;
Pilz, Stefan ;
Malle, Oliver .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2020, 74 (11) :1498-1513
[7]   Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity [J].
Anastassopoulou, Cleo ;
Gkizarioti, Zoi ;
Patrinos, George P. ;
Tsakris, Athanasios .
HUMAN GENOMICS, 2020, 14 (01)
[8]   Analysis of Vitamin D Receptor Gene Polymorphisms in Vitiligo [J].
Aydingoz, Ikbal Esen ;
Bingul, Ilknur ;
Dogru-Abbasoglu, Semra ;
Vural, Pervin ;
Uysal, Mujdat .
DERMATOLOGY, 2012, 224 (04) :361-368
[9]   Vitamin D can prevent COVID-19 infection-induced multiple organ damage [J].
Aygun, Hatice .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (07) :1157-1160
[10]  
Biesalski Hans K, 2020, NFS J, V20, P10, DOI 10.1016/j.nfs.2020.06.001